#deramiocel

Health

Capricor Therapeutics Faces FDA Rejection for Duchenne Treatment

By Editor • August 20, 2026 • 1 min read

Capricor Therapeutics' efforts to prevent FDA rejection of its Duchenne muscular dystrophy treatment appear futile, requiring a new clinical trial for approval.

Health

A Journey of Independence Amidst Uncertainty in Duchenne Treatment

By Editor • August 20, 2026 • 1 min read

Despite challenges, my son prepares for his second year of graduate studies while facing uncertainty over Capricor's Duchenne muscular dystrophy treatment.